A Study of TAK-861 in Participants With Narcolepsy Type 2

PHASE2CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

January 9, 2023

Primary Completion Date

December 13, 2023

Study Completion Date

December 25, 2023

Conditions
Narcolepsy Type 2
Interventions
DRUG

Placebo

TAK-861 placebo matching tablets.

DRUG

TAK-861 2 mg

TAK-861 2 mg tablets.

DRUG

TAK-861 2 mg and 5 mg

TAK-861 2 mg and 5 mg tablets.

Trial Locations (56)

1004

Hospital Universitario Araba Santiago, Vitoria-Gasteiz

2037

Woolcock Institute of Medical Research, Glebe

3010

Universitaetsspital Bern - Inselspital, Bern

5017

Klinik Barmelweid AG, Barmelweid

6900

Neurocenter of Southern Switzerland, Lugano

10117

Advanced Sleep Research GmbH, Berlin

12004

Hospital General Universitari de Castello, Castellon

19053

Somni Bene Institut fur Medizinische Forschung und Schlafmedizin Schwerin GmbH, Schwerin

28036

Instituto de Investigaciones del Sueno, Madrid

28037

Research Carolina Elite, Denver

28043

Hospital Vithas Madrid Arturo Soria, Madrid

34090

Hopital Saint-Eloi, Montpellier

38700

CHU de Grenoble, La Tronche

40139

IRCCS Istituto delle Scienze Neurologiche di Bologna, Bellaria

44195

The Cleveland Clinic Foundation, Cleveland

45212

Tricoastal Narcolepsy and Sleep Disorders Center, PLLC, Cincinnati

46600

Hospital de La Ribera, Alzira

48377

Henry Ford Medical Center - Columbus, Novi

75013

Hopital de la Pitie Salpetriere, Paris

80918

Delta Waves LLC - Hunt - PPDS, Colorado Springs

86077

Istituto Neurologico Mediterraneo Neuromed, Pozzilli

94063

Stanford Center for Sleep Sciences and Medicine, Redwood City

35213-1966

Sleep Disorders Center of Alabama, Birmingham

85259-5452

Mayo Clinic Arizona-PPDS, Scottsdale

92705-8519

SDS Clinical Trials, Inc., Santa Ana

32803-1468

Florida Pediatric Research Institute, Orlando

30342-1743

Neurotrials Research, Atlanta

30501-3883

Georgia Neuro Center, Gainesville

02459

Neurocare Inc., Newton

63017-3406

St. Lukes Sleep Medicine and Research Center, Chesterfield

28078-5082

ARSM Research, LLC, Huntersville

45227-2172

Intrepid Research, Cincinnati

43017-3521

Ohio Sleep Medicine Institute, Dublin

29425-5712

Medical University of South Carolina - PPDS, Charleston

29201-2923

Bogan Sleep Consultants, LLC, Columbia

77030-2042

Comprehensive Sleep Medicine Associates - Sugar Land, Houston

78229-4849

Sleep Therapy and Research Center, San Antonio

23510-1021

Children's Specialty Group, Norfolk

00380

Terveystalo Helsinki Sleep Clinic, Helsinki

00133

Fondazione PTV Policlinico Tor Vergata, Rome

010-8543

Akita University Hospital, Akita

791-0295

Ehime University Hospital, Toon-Shi

806-0021

You Ariyoshi Sleep Clinic, Kitakyushu

830-0011

Kurume University Hospital, Kurume-Shi

862-0954

Howakai Kuwamizu Hospital, Kumamoto

532-0003

Gokeikai Osaka Kaisei Hospital, Osaka

112-0012

Koishikawa Tokyo Hospital, Bunkyo-Ku

187-8551

National Center of Neurology and Psychiatry, Kodaira-Shi

151-0053

Yoyogi Sleep Disorder Center, Shibuya-Ku

480-1195

Aichi Medical University Hospital, Nagakute

222-0033

RESM respiratory and sleep medical-care clinic, Yokohama

5591 VE

Kempenhaeghe - PPDS, Heeze

2103 SW

Slaap-Waakcentrum SEIN Heemstede, Heemstede

0450

Oslo Universitetssykehus HF Rikshospitalet, Oslo

08036

Hospital Clinic de Barcelona, Barcelona

413 90

Sahlgrenska Universitetssjukhuset, Gothenburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY